Literature DB >> 28110436

Contribution of inducible and neuronal nitric oxide synthases to mitochondrial damage and melatonin rescue in LPS-treated mice.

José Antonio García1,2, Francisco Ortiz1,2, Javier Miana3, Carolina Doerrier1,2, Marisol Fernández-Ortiz1,2, Iryna Rusanova1,2, Germaine Escames1,2,4, José Joaquín García3, Darío Acuña-Castroviejo5,6,7,8.   

Abstract

NOS isoform activation is related to liver failure during sepsis, but the mechanisms driving mitochondrial impairment remain unclear. We induced sepsis by LPS administration to inducible nitric oxide synthase (iNOS-/-) and neuronal nitric oxide synthase (nNOS-/-) mice and their respective wild-type controls to examine the contribution of iNOS to mitochondrial failure in the absence of nNOS. To achieve this goal, the determination of messenger RNA (mRNA) expression and protein content of iNOS in cytosol and mitochondria, the mitochondrial respiratory complex content, and the levels of nitrosative and oxidative stress (by measuring 3-nitrotyrosine residues and carbonyl groups, respectively) were examined in the liver of control and septic mice. We detected strongly elevated iNOS mRNA expression and protein levels in liver cytosol and mitochondria of septic mice, which were related to enhanced oxidative and nitrosative stress, and with fewer changes in respiratory complexes. The absence of the iNOS, but not nNOS, gene absolutely prevented mitochondrial impairment during sepsis. Moreover, the nNOS gene did not modify the expression and the effects of iNOS here shown. Melatonin administration counteracted iNOS activation and mitochondrial damage and enhanced the expression of the respiratory complexes above the control values. These effects were unrelated to the presence or absence of nNOS. iNOS is a main target to prevent liver mitochondrial impairment during sepsis, and melatonin represents an efficient antagonist of these iNOS-dependent effects whereas it may boost mitochondrial respiration to enhance liver survival.

Entities:  

Keywords:  Free radicals; LPS; Liver; Melatonin; Mitochondria; Nitric oxide synthase

Mesh:

Substances:

Year:  2017        PMID: 28110436     DOI: 10.1007/s13105-017-0548-2

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  53 in total

Review 1.  Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence.

Authors:  Germaine Escames; Darío Acuña-Castroviejo; Luis Carlos López; Dun-xian Tan; Maria Dolores Maldonado; Marina Sánchez-Hidalgo; Josefa León; Russel J Reiter
Journal:  J Pharm Pharmacol       Date:  2006-09       Impact factor: 3.765

2.  Mitochondrial nitric oxide synthase.

Authors:  Paul S Brookes
Journal:  Mitochondrion       Date:  2004-03       Impact factor: 4.160

3.  Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations.

Authors:  Carmen Venegas; José A García; Germaine Escames; Francisco Ortiz; Ana López; Carolina Doerrier; Laura García-Corzo; Luis C López; Russel J Reiter; Darío Acuña-Castroviejo
Journal:  J Pineal Res       Date:  2011-09-02       Impact factor: 13.007

4.  Distribution of nitric oxide synthase in normal and cirrhotic human liver.

Authors:  Lance McNaughton; Lakshmi Puttagunta; Maria Angeles Martinez-Cuesta; Norm Kneteman; Irvin Mayers; Redwan Moqbel; Qutayba Hamid; Marek W Radomski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

5.  Purification and characterization of a nitric-oxide synthase from rat liver mitochondria.

Authors:  A Tatoyan; C Giulivi
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

6.  Mammalian mitochondrial nitric oxide synthase: characterization of a novel candidate.

Authors:  Tomasz Zemojtel; Mateusz Kolanczyk; Nadine Kossler; Sigmar Stricker; Rudi Lurz; Ivan Mikula; Marlena Duchniewicz; Markus Schuelke; Pedram Ghafourifar; Pavel Martasek; Martin Vingron; Stefan Mundlos
Journal:  FEBS Lett       Date:  2005-12-20       Impact factor: 4.124

7.  Nitric oxide synthase activity in mitochondria.

Authors:  P Ghafourifar; C Richter
Journal:  FEBS Lett       Date:  1997-12-01       Impact factor: 4.124

8.  Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin.

Authors:  G M Wray; C G Millar; C J Hinds; C Thiemermann
Journal:  Shock       Date:  1998-05       Impact factor: 3.454

9.  The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.

Authors:  C Thiemermann; H Ruetten; C C Wu; J R Vane
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

10.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.

Authors:  J D MacMicking; C Nathan; G Hom; N Chartrain; D S Fletcher; M Trumbauer; K Stevens; Q W Xie; K Sokol; N Hutchinson
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

View more
  10 in total

Review 1.  Melatonin, clock genes and mitochondria in sepsis.

Authors:  Darío Acuña-Castroviejo; Ibtissem Rahim; Carlos Acuña-Fernández; Marisol Fernández-Ortiz; Jorge Solera-Marín; Ramy K A Sayed; María E Díaz-Casado; Iryna Rusanova; Luis C López; Germaine Escames
Journal:  Cell Mol Life Sci       Date:  2017-08-07       Impact factor: 9.261

Review 2.  Melatonin and the electron transport chain.

Authors:  Rüdiger Hardeland
Journal:  Cell Mol Life Sci       Date:  2017-08-07       Impact factor: 9.261

Review 3.  Melatonin Scavenger Properties against Oxidative and Nitrosative Stress: Impact on Gamete Handling and In Vitro Embryo Production in Humans and Other Mammals.

Authors:  Pía Loren; Raúl Sánchez; María-Elena Arias; Ricardo Felmer; Jennie Risopatrón; Carolina Cheuquemán
Journal:  Int J Mol Sci       Date:  2017-06-14       Impact factor: 5.923

Review 4.  Protective Effects of Melatonin on the Skin: Future Perspectives.

Authors:  Iryna Rusanova; Laura Martínez-Ruiz; Javier Florido; César Rodríguez-Santana; Ana Guerra-Librero; Darío Acuña-Castroviejo; Germaine Escames
Journal:  Int J Mol Sci       Date:  2019-10-08       Impact factor: 5.923

Review 5.  Thymus-Pineal Gland Axis: Revisiting Its Role in Human Life and Ageing.

Authors:  Rita Rezzani; Caterina Franco; Rüdiger Hardeland; Luigi Fabrizio Rodella
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 6.  Potential Effects of Melatonin and Micronutrients on Mitochondrial Dysfunction during a Cytokine Storm Typical of Oxidative/Inflammatory Diseases.

Authors:  Virna Margarita Martín Giménez; Natalia de Las Heras; León Ferder; Vicente Lahera; Russel J Reiter; Walter Manucha
Journal:  Diseases       Date:  2021-04-14

7.  Effects of Angiotensin-Neprilysin Inhibition in Canines with Experimentally Induced Cardiorenal Syndrome.

Authors:  Hani N Sabbah; Kefei Zhang; Ramesh C Gupta; Jiang Xu; Vinita Singh-Gupta
Journal:  J Card Fail       Date:  2020-08-22       Impact factor: 5.712

8.  Effects of elamipretide on skeletal muscle in dogs with experimentally induced heart failure.

Authors:  Hani N Sabbah; Ramesh C Gupta; Vinita Singh-Gupta; Kefei Zhang
Journal:  ESC Heart Fail       Date:  2019-01-28

9.  The Protective Effects of Melatonin Against LPS-Induced Septic Myocardial Injury: A Potential Role of AMPK-Mediated Autophagy.

Authors:  Shouyin Di; Zheng Wang; Wei Hu; Xiaolong Yan; Zhiqiang Ma; Xiaofei Li; Weimiao Li; Jianyuan Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-16       Impact factor: 5.555

10.  The Impact of Melatonin and NLRP3 Inflammasome on the Expression of microRNAs in Aged Muscle.

Authors:  Ramy Ka Sayed; Marisol Fernández-Ortiz; José Fernández-Martínez; Paula Aranda Martínez; Ana Guerra-Librero; César Rodríguez-Santana; Tomás de Haro; Germaine Escames; Darío Acuña-Castroviejo; Iryna Rusanova
Journal:  Antioxidants (Basel)       Date:  2021-03-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.